back to company universe
AI infrastructure

OncoRevive

Revolutionizing cancer care with AI-powered liquid biopsy for early detection and personalized treatment.

sources
2
Evidence entries preserved.
affiliations
2
Antler, Techstars
competitors
6
Mapped from High Signal graph features.
status
generated
D1 lookup
last updated
2026-07-15
16:41 UTC
source evidence
Why this company exists here

Antler

antler-portfolio #1416

Revolutionizing cancer care with AI-powered liquid biopsy for early detection and personalized treatment.

source

Techstars

techstars-portfolio #1911

Developing a nanotechnology-based AI-powered blood test for cancer monitoring

source
generated read
High Signal interpretation

OncoRevive is classified as AI infrastructure from source descriptions and fund-directory context. Similar companies below are ranked from offline product facets and meaningful description overlap; category and source affiliation can only strengthen an existing product match. For lookup-created rows, the profile starts as pending enrichment until deeper source collection runs.

offline extraction
Product facets
AI-powered liquid biopsyAI-powered blood testcancer carepersonalized treatment
mapping method
Similarity graph

Local clusters rerank extracted product concepts and description terms. The generated graph remains the fallback for sparse descriptions: offline reciprocal product-similarity graph: extracted concepts + description terms + bounded category/affiliation boosts. Minimum fallback score: 0; max competitors: 6.

discovery cluster

Companies similar to OncoRevive

AI infrastructure · 6 peers

A deterministic local cluster built from offline product facets and meaningful description terms. Category and selected-institution affiliation provide bounded tie-breaks. Open any peer to continue exploring its cluster.

allumbra

match 66

allumbra develops a blood test for oncologists and cancer centers that uses photonics and AI to detect early cancer recurrence in head and neck cancer survivors, addressing the need for accurate and affordable monitoring in a market with limited options

shared extracted concept terms: cancer, blood, test; shared product terms: blood, test, cancer, early; same category: AI infrastructure; shared affiliation: Techstars

Prima Mente

match 64

CFDX aims to apply the liquid biopsy techniques used in early cancer detection to neurodegenerative diseases, enabling diagnosis decades before symptoms appear.

shared extracted concept terms: liquid, biopsy; shared product terms: cancer, liquid, biopsy, early; same category: AI infrastructure; shared affiliation: Antler

Delee

match 55

Delee is a medical device company that developed a blood-testing device for early diagnosis of cancer and treatment monitoring through the isolation and analysis of the circulating tumor cells.

shared extracted concept terms: treatment; shared product terms: blood, test, early, cancer; shared product theme: health and clinical care

PreDxion Bio

match 49

PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine

shared extracted concept terms: test, care; shared product terms: care, detection, test; shared product theme: health and clinical care

Luminate

match 41

We make cancer care at home possible.

shared extracted concept terms: cancer, care; shared product terms: cancer, care; shared product theme: health and clinical care

Atomic Alchemy

match 41

Atomic Alchemy is building a bank of reactors to produce the nuclear material that goes into nuclear medicine. Radiopharmaceuticals are vitally important in biological tracers, diagnostic imaging, and cancer treatments. Currently, the world's supply of Molybdenum-99, the cornerstone of 80% of all nuclear medicine procedures, is sourced from just six government-run, scientific research reactors abroad. Five of these reactors are 45-65 years old and are quickly coming to the end of their operation

shared extracted concept terms: cancer, treatment; shared product terms: cancer, treatment; shared product theme: health and clinical care